APA (7th ed.) Citation

Marcus, P., Warrington, J., Zhang, M., Ankathatti-Munegowda, M., Wang, X., Rashedi, I., & Keating, A. (2026). Intraperitoneal administration of NK-92 improves survival in xenografts of early and established ovarian cancer models. PLoS ONE, 21(4), 1. https://doi.org/10.1371/journal.pone.0347095

Chicago Style (17th ed.) Citation

Marcus, Paula, Jenny Warrington, Michael Zhang, Manjunatha Ankathatti-Munegowda, Xing-Hua Wang, Iran Rashedi, and Armand Keating. "Intraperitoneal Administration of NK-92 Improves Survival in Xenografts of Early and Established Ovarian Cancer Models." PLoS ONE 21, no. 4 (2026): 1. https://doi.org/10.1371/journal.pone.0347095.

MLA (9th ed.) Citation

Marcus, Paula, et al. "Intraperitoneal Administration of NK-92 Improves Survival in Xenografts of Early and Established Ovarian Cancer Models." PLoS ONE, vol. 21, no. 4, 2026, p. 1, https://doi.org/10.1371/journal.pone.0347095.